ATE413882T1 - 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren - Google Patents

2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren

Info

Publication number
ATE413882T1
ATE413882T1 AT03751812T AT03751812T ATE413882T1 AT E413882 T1 ATE413882 T1 AT E413882T1 AT 03751812 T AT03751812 T AT 03751812T AT 03751812 T AT03751812 T AT 03751812T AT E413882 T1 ATE413882 T1 AT E413882T1
Authority
AT
Austria
Prior art keywords
sub
inhibitors
reuppose
phenylthiomethyl
morpholine derivatives
Prior art date
Application number
AT03751812T
Other languages
English (en)
Inventor
Magnus Wilhelm Walter
Barry Peter Clark
Peter Thaddeus Gallagher
Helen Louise Haughton
Helene C E Rudyk
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0219690A external-priority patent/GB0219690D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE413882T1 publication Critical patent/ATE413882T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT03751812T 2002-08-23 2003-08-18 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren ATE413882T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0219690A GB0219690D0 (en) 2002-08-23 2002-08-23 Benzyl morpholine derivatives
US41532802P 2002-10-01 2002-10-01

Publications (1)

Publication Number Publication Date
ATE413882T1 true ATE413882T1 (de) 2008-11-15

Family

ID=31948037

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03751812T ATE413882T1 (de) 2002-08-23 2003-08-18 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren

Country Status (7)

Country Link
US (1) US7384941B2 (de)
EP (1) EP1534291B1 (de)
AT (1) ATE413882T1 (de)
AU (1) AU2003269923A1 (de)
DE (1) DE60324685D1 (de)
ES (1) ES2315525T3 (de)
WO (1) WO2004017977A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2304140C2 (ru) 2001-12-27 2007-08-10 Дайити Фармасьютикал Ко., Лтд. ИНГИБИТОРЫ ПРОДУЦИРОВАНИЯ / СЕКРЕЦИИ β-АМИЛОИДНОГО БЕЛКА
WO2004018440A1 (en) 2002-08-23 2004-03-04 Eli Lilly And Company Benzyl morpholine derivatives
GB0219687D0 (en) * 2002-08-23 2002-10-02 Lilly Co Eli Benzyl morpholine derivatives
RU2336270C2 (ru) * 2003-06-30 2008-10-20 Дайити Фармасьютикал Ко., Лтд. Гетероциклические метилсульфоновые производные
GB0319793D0 (en) 2003-08-22 2003-09-24 Lilly Co Eli Pyridinylmorpholine derivatives
ATE399557T1 (de) * 2003-12-12 2008-07-15 Lilly Co Eli Selektive norepinephrin-wiederaufnahmehemmer zur behandlung von hitzewallungen
DE602004019698D1 (de) * 2003-12-23 2009-04-09 Lilly Co Eli Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin
AP2006003771A0 (en) * 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
WO2007005935A2 (en) * 2005-07-06 2007-01-11 Molecular Neuroimaging, Llc Norepinephrine transporter radiotracers and methods of syntheses thereof
ES2434250T3 (es) 2008-07-24 2013-12-16 Theravance, Inc. Compuestos de 3-(fenoxifenilmetil)pirrolidina
PT2358675E (pt) 2008-11-14 2012-12-12 Theravance Inc Compostos de 4-[2-(2-fluorofenoximetil)fenil]piperidina
WO2010120910A1 (en) * 2009-04-15 2010-10-21 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
US7994209B2 (en) * 2009-07-13 2011-08-09 Theravance, Inc. 3-phenoxymethylpyrrolidine compounds
JP5714580B2 (ja) 2009-07-21 2015-05-07 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー 3−フェノキシメチルピロリジン化合物
US8778949B2 (en) * 2010-01-11 2014-07-15 Theravance Biopharma R&D Ip, Llc 1-(2-phenoxymethylphenyl)piperazine compounds
ES2543064T3 (es) * 2010-03-22 2015-08-14 Theravance Biopharma R&D Ip, Llc Compuestos de 1-(2-fenoximetilheteroaril)piperidina y piperazina
ES2533434T3 (es) 2010-10-11 2015-04-10 Theravance Biopharma R&D Ip, Llc Inhibidores de la captación de la serotonina
WO2012075239A1 (en) 2010-12-03 2012-06-07 Theravance, Inc. Serotonin reuptake inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759013R (fr) * 1969-11-17 1971-05-17 Ici Ltd Derives de la
GB1412546A (en) * 1973-08-08 1975-11-05 Ici Ltd Morpholine derivatives
GB2167407B (en) * 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
US5658590A (en) 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
CN1195287A (zh) 1995-07-24 1998-10-07 伊莱利利公司 注意力涣散/多动症的治疗
WO1999015177A1 (en) 1997-09-23 1999-04-01 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
IL137346A0 (en) * 1998-01-21 2001-07-24 Glaxo Group Ltd Pharmaceutically active morpholinol
GB9812662D0 (en) 1998-06-11 1998-08-12 Merck Sharp & Dohme Therapeutic use
US6503905B1 (en) 1998-12-29 2003-01-07 Pfizer Inc 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
HUP0105488A3 (en) 1999-02-23 2005-07-28 Pfizer Prod Inc Monoamine reuptake inhibitors for treatment of cns disorders and pharmaceutical compositions containing the compounds
DE60035232T2 (de) 1999-07-01 2008-02-14 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom

Also Published As

Publication number Publication date
WO2004017977A2 (en) 2004-03-04
AU2003269923A8 (en) 2004-03-11
DE60324685D1 (de) 2008-12-24
AU2003269923A1 (en) 2004-03-11
ES2315525T3 (es) 2009-04-01
EP1534291A2 (de) 2005-06-01
US20060035894A1 (en) 2006-02-16
WO2004017977A3 (en) 2004-04-01
EP1534291B1 (de) 2008-11-12
US7384941B2 (en) 2008-06-10

Similar Documents

Publication Publication Date Title
ATE413882T1 (de) 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren
BRPI0413232A (pt) novos compostos tendo atividade inibitória contra os trasnportadores dependentes de sódio
MXPA04001258A (es) Activador para el receptor d que responde al proliferador de peroxisoma.
EP1642880A4 (de) Proteininhibitoren der hsp90-familie
EP1104764A4 (de) 1h-imidazopyridin-derivate
ATE377004T1 (de) Proteinkinaseinhibitoren
DE60331187D1 (de) Kinaseinhibitoren
HRP20000406B1 (en) Arylpiperazines having activity at the serotonin 1a receptor
PH12015501098A1 (en) Antituberculous composition comprising oxazole compounds
FI821733A0 (fi) Blodtryckssaenkande 1-substituerade spiropiperidinoxobenzoxazin/t
DE602004020730D1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
ATE374750T1 (de) Serotoninwiederaufnahme-inhibitoren
NO971687D0 (no) Diazepinoindoler som forsfodiesterase IV-inhibitorer
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
EA200101230A1 (ru) Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции
ATE343566T1 (de) Propanamine derivate als serotonin und norepinephrin reuptake-inhibitoren
EA200200523A1 (ru) Новые разветвленные замещенные аминопроизводные 3-амино-1-фенил-1h[1,2,4]триазола, способы их получения и содержащие их фармацевтические композиции
DK1628968T3 (da) 4-imidazolin-2-on-forbindelser
EA200800149A1 (ru) 4,5-диарилпиррольные производные, способ их получения и применение в терапии
EA200101050A1 (ru) Замещенные бензолактамные соединения
ATE497497T1 (de) 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung
UA89619C2 (ru) Соединения пиперазина, способ их получения и фармацевтическая композиция, которая их содержит
ATE327982T1 (de) Benzylmorpholinderivate
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties